Virtu Financial LLC Increases Stake in Eli Lilly and Company
Dec 12, 2024
Lilly Investment Portfolios
Eli Lilly's $15 Billion Buyback and Stock Performance Analysis
Dec 10, 2024
Lilly's Tirzepatide Shows Promising Results in MASH Resolution and Fibrosis Improvement
Jun 9, 2024